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systems and to evaluate their potential as targets for analgesia under 
conditions of neuropathy.
M CURRENTS: FUNCTION AND MODULATION
In 1998, the molecular substrates for the M current were ﬁ  rst 
identiﬁ  ed as KCNQ2 and KCNQ3 channels (Wang et al., 1998) 
and later on, KCNQ4 and KCNQ5 were also found to contribute 
to generate M currents (Kubisch et al., 1999; Lerche et al., 2000; 
Schroeder et al., 2000). The remaining member of the family, 
KCNQ1, is heavily expressed in the heart but not in nervous sys-
tem (Jentsch, 2000; Robbins, 2001). The present nomenclature for 
ion channels has renamed them as Kv7.1, Kv7.2, Kv7.3, Kv7.4 and 
Kv7.5 respectively and we will use this nomenclature from here 
onwards (Gutman et al., 2003).
Functional Kv7 channels require homomeric or heteromeric 
assemblies of four subunits. However, only the Kv7.3 subunit is 
able to form heteromeric channels with other members of the 
family (for review see Robbins, 2001). Kv7 proteins consist of six 
transmembrane domains and their structure has been studied in 
detail (Jentsch, 2000). Several sites of functional relevance have been 
described including phosphorylation sites (Schroeder et al., 1998; 
Surti et al., 2005), a calmodulin-binding site (Etxeberria et al., 2008; 
Yus-Najera et al., 2002) and binding sites for AKAP and ankyrin-
G (Hoshi et al., 2003; Pan et al., 2006). The general functions of 
these channels in the nervous system have been recently reviewed 
elsewhere (Brown and Passmore, 2009).
M CURRENT AND NEURONAL EXCITABILITY
As expected from the various combinations of proteins that can 
form functional currents, there is not a single M current but 
rather a family of them that share some major traits. The classi-
cal IM is a voltage dependent non-inactivating potassium current 
with a slow activation process which starts at membrane poten-
tials close to rest (Brown and Yu, 2000). Molecular variations 
affect channel conductance and the sensitivity to modulators 
(Robbins, 2001).
INTRODUCTION
Potassium channels constitute a very wide family of ionic channels 
that are present in most biological entities. Individual subunits can 
combine to form heteromeric channels and post-transcriptional 
modiﬁ  cations of these subunits are possible yielding a great variety 
of potassium currents. Genetic defects in genes coding potassium 
channel subunits have been related to human diseases indicating the 
great importance that they have in cellular and systems physiology 
(Kullmann, 2002).
In excitable cells potassium channels are responsible for the 
control and regulation of excitability. The activity of individual 
potassium channels or combinations of them can determine rest-
ing potential, membrane resistance, action potential shape and ﬁ  r-
ing adaptation. In addition, the antinociceptive action of several 
endogenous mediators like opioids as well as some anesthetics, are 
partly mediated by actions on potassium channels (Ocana et al., 
2004). For these reasons, there is an increasing interest in study-
ing the involvement of potassium channels in the sensitization of 
nociceptive systems (Hu et al., 2006).
M currents (IM) and the underlying KCNQ or Kv7 channels have 
been related to several channelopathies that involve hyperexcitabil-
ity in neurons of various areas of the nervous system. These include 
benign neonatal epilepsy and other forms of epilepsy, myokymia 
and peripheral nerve excitability (Maljevic et al., 2008). Several cues 
suggest that opening of M currents with speciﬁ  c anticonvulsants 
may be a valid target for analgesia in neuropathic pain states. In 
ﬁ  rst place, anticonvulsants with different mechanisms of action 
like pregabalin and gabapentin are being successfully used for neu-
ropathic pain therapy. In second place, basic research is providing 
evidence showing abundant expression of functional M currents 
in primary afferents and the spinal cord, both key elements for 
nociceptive processing. Finally, some M current modulators are 
showing promising signs of pain relieve in animal models of neu-
ropathic pain.
Here we review experimental work that has contributed to deﬁ  ne 
M currents, to assess their presence and function in nociceptive 
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Because of its low activation threshold, it can contribute to 
maintain the resting potential together with other conductances 
(Lamas et al., 2002). At resting membrane potential there are very 
few operative ionic currents and therefore a large membrane resist-
ance. In these conditions, although Kv7 channels are only starting 
to open, the small currents generated may have a large impact on 
resting potential. In agreement with this theoretical interpreta-
tion, modulation of Kv7 channels has been reported to produce 
changes in resting membrane potentials and/or input resistance 
in many neuronal types (Brown and Adams, 1980; Koyama and 
Appel, 2006; Lawrence et al., 2006; Lechner et al., 2003; Murase 
et al., 1986; Nowak and Macdonald, 1982, 1983a,b; Otto et al., 
2002; Passmore et al., 2003; Rivera-Arconada and Lopez-Garcia, 
2005; Romero et al., 2004; Wladyka and Kunze, 2006; Yue and Yaari, 
2004). As a consequence of the effects on resting potential, Kv7 
channels (particularly those containing Kv7.2 subunits) have been 
implicated in the modulation of neurotransmitter release (Lechner 
et al., 2003; Luisi et al., 2009; Martire et al., 2004, 2007).
M currents are active at potentials below the threshold for action 
potential initiation and tend to increase rapidly in magnitude with 
depolarization. This creates a force opposing to depolarization, 
delaying or precluding the ﬁ  ring of action potentials due to synaptic 
activation. Because the current does not inactivate but remains 
active during prolonged periods of depolarization it tends to reduce 
ﬁ  ring frequency. Modulation of Kv7 channels has an important 
impact on neuronal excitability as reported for many native neu-
rons. Block of Kv7 channels leads to a decrease in rheobase and a 
reduction in the spike frequency adaptation reducing the interspike 
interval, while channel opening facilitation tends to produce oppo-
site effects (Filippov et al., 2006; Hetka et al., 1999; Koyama and 
Appel, 2006; Lawrence et al., 2006; Lechner et al., 2003; Nowak and 
Macdonald, 1983a; Otto et al., 2002; Passmore et al., 2003; Peretz 
et al., 2005; Rivera-Arconada and Lopez-Garcia, 2005; Wladyka 
and Kunze, 2006; Yue and Yaari, 2004), but not always (Miles et al., 
2005; Romero et al., 2004).
ENDOGENOUS MODULATION OF M CURRENTS
Kv7 channels are modulated by a variety of endogenous compounds 
like neurotransmitters and peptides via the activation of intracel-
lular cascades of second messengers. Interestingly, most modulators 
produce a reduction of IM and hence tend to increase the excitability 
of the neurons affected (Brown and Yu, 2000).
Activation of muscarinic acetylcholine receptors was the ﬁ  rst 
pathway reported for M current modulation and the name of 
the current is related to this fact (Brown and Adams, 1980). 
Cholinergic inhibition of IM is a widespread mechanism and it 
has been conﬁ  rmed in many areas of the nervous system includ-
ing human cortical neurons (McCormick and Williamson, 1989). 
Cholinergic suppression of the current seems to be mediated by 
M1 receptors in most neuronal types tested (Marrion et al., 1989; 
Romero et al., 2004; Selyanko et al., 2000; Shen et al., 2005) but 
not in all of them (Rouse et al., 2000). The effect of muscarinic 
receptors on IM seems to be mediated by G-proteins of the Gq or 
G11 class (Caulﬁ  eld et al., 1994). In addition, it has been shown 
that PIP2 is a necessary cofactor for Kv7 function and that activa-
tion of muscarinic receptors produces PIP2 depletion (Suh and 
Hille, 2005).
Bradykinin has been shown to increase the excitability of SCG 
neurons inhibiting Kv7. This effect of bradykinin is mediated by 
B2 receptors and the activation of G alpha q/11 proteins acting via 
phospholipase C (Cruzblanca et al., 1998; Jones et al., 1995). This, 
in turn may cause increases in calcium concentration and closure 
of Kv7 channels (Brown et al., 2007; Delmas et al., 2002).
Several other endogenous mediators like serotonin and nerve 
growth factor have been implicated in IM reduction (Jia et al., 2008; 
McCormick and Williamson, 1989). Similarly, activation of CB1 
cannabinoid receptors (Schweitzer, 2000), P2Y purinergic recep-
tors (Adams et al., 1982; Filippov et al., 2006; Zaika et al., 2007) 
and metabotropic glutamate receptors (Charpak et al., 1990) may 
reduce M currents.
In contrast to these excitatory effects mediated by IM depression, 
opioids and somatostatin have been reported to reduce neuronal 
excitability by potentiating the current. Activation of kappa recep-
tors by modulators like dynorphin and nociceptin has been shown 
to depress the excitability of CA1 neurons (Madamba et al., 1999a,b; 
Moore et al., 1994). In this region of the CNS, somatostatin (and 
corticostatin) has been shown to augment the M current (de Lecea 
et al., 1996; Moore et al., 1988) activating the subtype 4 receptor 
(Qiu et al., 2008) and a subsequent pathway implicating arachidonic 
acid metabolites (Schweitzer et al., 1990). In neurons of the soli-
tary tract somatostatin produces hyperpolarization and depresses 
  excitability increasing Kv7 currents (Jacquin et al., 1988).
With the exception of muscarine and substance P, there is no 
evidence that the other mentioned receptors and endogenous 
modulators may act on M currents to regulate pain processing. 
Of special interest in our context is the recent work performed on 
small diameter dorsal root ganglion cells (presumed nociceptors) 
showing that activation of Mas-related gene receptor D and pro-
tease-activated receptor 2 cause inhibition of M currents and an 
abnormal excitability in nociceptive pathways which may be related 
to the origin of naturally occurring hyperalgesia after inﬂ  ammation 
(Crozier et al., 2007; Linley et al., 2008).
EXOGENOUS MODULATORS OF M CURRENTS
Selective agonists and antagonists are extremely useful tools to 
evaluate the roles of ion channels and receptors at the systems level. 
The ﬁ  rst compounds known to act as M current modulators with 
a certain degree of potency and selectivity were linopirdine (chan-
nel blocker) and retigabine (channel opener). Although Kv7 chan-
nels are sensitive to tetraethylammonium (Hadley et al., 2000) this 
compound is not selective and blocks a variety of other potassium 
conductances. Linopirdine probably exerts its effect on Kv7 chan-
nels at the external side of the membrane (Costa and Brown, 1997). 
Important residues for the effect of retigabine on Kv7  channels are 
located within the pore region (Lange et al., 2009; Schenzer et al., 
2005; Wuttke et al., 2005).
Linopirdine [3,3-bis(4-pyridinylmethyl)-1-phenylindolin-2-
one, DUP996] was described as a cognition enhancer that increases 
stimulus evoked neurotransmitter release in hippocampus without 
altering basal release. For this reason, it was proposed for the treat-
ment of Alzheimer’s disease (Tam and Zaczek, 1995). The mecha-
nism of action of linopirdine is mostly mediated by Kv7 channel 
closure (Aiken et al., 1995), although effects on other potassium 
channels and receptors cannot be excluded (Lamas et al., 1997; Frontiers in Molecular Neuroscience  www.frontiersin.org  August 2009  | Volume 2  |  Article 10  |  3
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Schnee and Brown, 1998). Some analogs of linopirdine show similar 
properties (Zaczek et al., 1998). Among them XE991 [10,10-bis(4-
pyridinylmethyl)-9(10H)-anthracenone] has been widely used for 
Kv7 channel studies because it has greater afﬁ  nity and selectiv-
ity values than linopirdine for native M currents (Robbins, 2001; 
Schroder et al., 2001; Wang et al., 1998). These compounds also 
block cardiac Kv7.1 channels at low concentrations, however in 
native cardiac cells Kv7.1 associates with other accessory subunits 
that render the resulting current less sensitive to XE991 (Wang 
et al., 2000).
Kv7 channel blockers have been widely used for the identiﬁ  cation 
of M currents in several neuronal types. In many neurons includ-
ing dorsal root ganglion and spinal cord neurons, application of 
XE991 produces depolarization and an increase in the ﬁ  ring fre-
quency to depolarizing stimuli (Aiken et al., 1995; Alaburda et al., 
2002; Lawrence et al., 2006; Otto et al., 2002, 2006; Passmore et al., 
2003; Peters et al., 2005; Rivera-Arconada and Lopez-Garcia, 2005; 
Wladyka and Kunze, 2006; Yue and Yaari, 2004). However some 
neurons show weak responses to XE991 even if they have Kv7 chan-
nels (Miles et al., 2005; Rivera-Arconada and Lopez-Garcia, 2005; 
Romero et al., 2004). This may be due to the subunit composition 
of the different channels or to the expression of other dominant 
currents in the same neuron. In many studies, Kv7 channel blockers 
have been used as antagonist to test the speciﬁ  city of retigabine on 
M currents (Blackburn-Munro and Jensen, 2003; Dost et al., 2004; 
Passmore et al., 2003; Rivera-Arconada and Lopez-Garcia, 2005, 
2006; Rivera-Arconada et al., 2004; Roza and Lopez-Garcia, 2008; 
Yue and Yaari, 2004).
Retigabine [D23129, ethyl N-(2-amino-4-(4-ﬂ  uorobenzylamino)-
phenyl] activates M currents produced by heterologous expression of 
Kv7.2/3 (Main et al., 2000; Rundfeldt and Netzer, 2000b; Wickenden 
et al., 2000). At concentrations between 0.1 and 10-µM retigab-
ine modiﬁ  es the voltage dependence of these channels, increases 
the activation rate, slows its inactivation and favors the open channel 
conﬁ  guration (Tatulian and Brown, 2003). Interestingly retigabine 
does not affect currents mediated by Kv7.1 channels. At larger con-
centrations, retigabine has been found to interact with GABA-ergic 
systems in some studies (Kapetanovic et al., 1995; Otto et al., 2002; 
Rundfeldt and Netzer, 2000a; van Rijn and Willems-van Bree, 2003) 
but not in others (Hetka et al., 1999).
Application of retigabine produces hyperpolarization and pro-
motes spike frequency adaptation in several neuronal types includ-
ing spinal cord neurons (Rivera-Arconada and Lopez-Garcia, 2005), 
dorsal root ganglion (Passmore et al., 2003), cortical (Hetka et al., 
1999; Otto et al., 2002) and hippocampal neurons (Yue and Yaari, 
2004). Retigabine also produces a reduction in neurotransmitter 
release induced by depolarization in synaptosomes (Luisi et al., 
2009; Martire et al., 2004, 2007).
Due to their interesting and promising pharmacological prop-
erties, new Kv7 channel openers have been developed recently 
and Kv7 channel opener properties have been reported in exist-
ing compounds. Among these are ﬂ  upirtine,  BMS-204352, 
diclofenac, ICA-27243, several acrylamides and Zinc pyrithione 
(Dalby-Brown et al., 2006, Xiong et al., 2008). Diclofenac and 
meclofenamic acid are commonly used anti-inﬂ  ammatory drugs 
which activate Kv7 channels (Peretz et al., 2005). The design of 
new derivates that   maintain Kv7 enhancing properties without 
cyclooxygenase activity may lead to obtain potent and subunit 
speciﬁ  c Kv7 modulators that could be applicable to pain treat-
ment (Peretz et al., 2007).
Kv7 CHANNELS AND M CURRENTS IN SENSORY AFFERENTS
Primary afferents are highly specialized elements of sensory systems 
comprising four differentiated domains with specialized functions, 
i.e., peripheral nerve endings, conducting axons, central terminals 
and cell bodies. Ion channels are distributed in an orderly and 
inhomogeneous form in each domain contributing in a decisive 
way to the signaling properties of individual ﬁ  bers. Alterations in 
the quantitative expression or the orderly distribution of ion chan-
nels induced by injury may have profound effects in these signal-
ing properties. The paragraphs bellow describe the experimental 
evidence supporting the presence of Kv7 channels in afferents and 
the functional consequences that may derive.
PERIPHERAL NERVE ENDINGS
Peripheral terminals contain the machinery required for trans-
duction and coding of external stimuli. Several potassium con-
ductances contribute to shape receptor potentials and to modulate 
coding properties of individual afferents (Belmonte and Viana, 
2008). Several lines of evidence suggest the presence of Kv7 chan-
nels or the existence of M currents at specialized receptor endings 
(Barnes, 1994; Buniel et al., 2008). Wladyka et al. (2008) studied the 
sensory terminals of arterial baroreceptors and found expression 
of Kv7.2/3/5 channel subunits as well as modulation of pressure–
response relations by retigabine and XE991. These results indicate 
that Kv7 channels are likely contributors to coding process, at least 
in certain receptors.
Cutaneous sensitivity has been explored using the skin-nerve 
preparation by several groups. We found that only a small propor-
tion of Aδ and C afferent ﬁ  bers responding to mechanical or chemi-
cal stimuli were responsive to XE991 and none of them responded 
to retigabine (Roza and Lopez-Garcia, 2008). We concluded that 
even if present in intact terminals, M currents must have a minor 
role at coding of acute nociceptive stimuli of cutaneous origin. In 
agreement with this observation, cutaneous application of XE991 
to live mice did not produce mechanical or thermal hyperalge-
sia (Linley et al., 2008). However, preliminary data from another 
group using the skin-nerve preparation (Passmore and Brown, 
2007) reported a depressant action of retigabine on noxious heat 
and mechanical responses. It is possible that differences between 
these two data sets were due to the use of different animals (mice 
and rats respectively) or different types of sensory neurons, but 
further clariﬁ  cation will be required.
CONDUCTING AXONS
Conduction of action potentials through myelinated and unmyeli-
nated axons involves two separated sets of mechanisms. At present, 
no data exist on the distribution and function of Kv7 channels along 
unmyelinated axons although electrophysiological experiments 
suggest the expression of functional M currents in this ﬁ  ber type. 
In myelinated ﬁ  bers, nodes of Ranvier at periodical interruptions 
of the myelin sheath enable saltatory conduction. Nodes are highly 
specialized structures enriched in sodium and potassium channels 
(Poliak and Peles, 2003). It has been shown that Kv7.2 channels are Frontiers in Molecular Neuroscience  www.frontiersin.org  August 2009  | Volume 2  |  Article 10  |  4
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2008; Passmore et al., 2003). Functional M currents with  standard 
bi  ophysics and pharmacological characteristics were found in 
large and small cells, some of them sensitive to capsaicin and 
therefore potential nociceptive ﬁ  bers. Immunoﬂ  uorescent analy-
sis showed that Kv7.2/3/5 subunits were present in ganglion cells 
probably producing functional channels of all possible combina-
tions. Modulation of M currents in dorsal root ganglion cells has 
been suggested as a mechanism to induce hyperexcitability during 
inﬂ  ammation (Linley et al., 2008).
M CURRENTS, AFFERENT FIBERS AND NEUROPATHY
Afferent ﬁ  bers are known to play a fundamental role in the origin 
and maintenance of neuropathic states. After injury, a percentage 
of myelinated and unmyelinated afferents may degenerate and die. 
The surviving afferents may regenerate and innervate new targets 
or fail to regenerate and form a neuroma (Lisney, 1989). In the 
area of damage, ﬁ  bers lose their myelin sheath and express a vari-
ety of membrane proteins such as transductors, receptors and ion 
channels normally not present in axons (Zimmermann, 2001). As 
a result these areas acquire the capacity to generate ectopic action 
potentials either spontaneously or in response to stimuli of different 
modalities. Similarly, axotomized dorsal root ganglion cells develop 
hyperexcitability and spontaneous activity (Amir et al., 2005).
Sodium channels are key elements for electrogenesis and a large 
number of observations indicate that they play an essential role 
in the development of ectopic activity (Devor, 2006). A role for 
potassium channels in ectopia has been anticipated on the basis of 
large increases in spontaneous activity produced by classic potas-
sium channel blockers such as 4-aminopyridine and tetraethylam-
monium (Devor, 1983). Recent work indicates that Kv7 channels 
may inﬂ  uence hyperexcitability of neuromatose ﬁ  bers. We used 
saphenous skin-nerve and nerve-end neuroma preparations to 
compare the effects of retigabine and XE991 on the coding prop-
erties of intact and neuromatose nerve endings (Roza and Lopez-
Garcia, 2008). To our surprise, retigabine was devoid of effect on 
responses of intact Aδ and C-ﬁ  bers to the stimulation of their recep-
tive ﬁ  eld. However responses of neuromatose Aδ and C-ﬁ  bers where 
completely blunted by retigabine. In addition, XE991 blocked the 
inhibitory effect of retigabine. Mechanistic studies indicated that 
retigabine hyperpolarized the areas of ectopic discharge generation 
decreasing the probability of ﬁ  ring action potentials. This mecha-
nism could operate to suppress activity independently of the nature 
of the stimulus and ﬁ  ber type. These ﬁ  ndings suggest that Kv7 chan-
nels gain an extraordinary important role in the control of ectopic 
discharges which may result from a complex rearrangement of the 
ion channels expressed at ectopic areas and/or an altered expression 
of Kv7 subunits as suggested by preliminary work (Wickenden et al., 
2002). A similar conclusion may be reached from work on isolated 
ﬁ  bers from human beings suffering from peripheral vascular dis-
ease or polyneuropathy (Lang et al., 2008). This altered sensitivity 
to retigabine in neuromatose ﬁ  bers generates a peripheral target 
of interest for analgesia in some forms of neuropathy.
Kv7 CHANNELS AND M CURRENTS IN THE SPINAL CORD
The spinal cord receives sensory inputs from the periphery becom-
ing the ﬁ  rst relay center for nociceptive information. The spinal 
cord processes the original sensory messages integrating  descending 
expressed in nodes of peripheral axons colocalized with sodium 
channels where they share an ankyrin-G-based mechanism of 
retention (Devaux et al., 2004; Pan et al., 2006). The Kv7.3 subu-
nit has also been detected in paranodes and Schmidt–Lanterman 
incisures in a relative small percentage of ﬁ  bers. It is noteworthy 
that Kv7.2 and Kv7.3 do not colocalize even when they are found 
in the same ﬁ  bers. Therefore, it is likely that Kv7.2 homomers con-
stitute the major contribution of Kv7 channels to nodal potassium 
currents, at least in peripheral ﬁ  bers.
A variety of nodal and perinodal potassium channels may con-
tribute to limit spike duration and frequency adaptation. Recently, 
Kv7.2 channels have been proposed to mediate the IKs (Schwarz 
et al., 2006), a slow potassium current previously detected at nodes 
(Dubois, 1981). XE991 has been shown to block IKs in single sci-
atic myelinated axons from rats maintained in vitro, the functional 
consequences being a decreased current threshold and a reduced 
adaptation to intracellular current pulses. Schwarz et al. (2006) 
showed that under in vivo conditions XE991 increase the excitability 
of motor axons. Accordingly, myokymia (neuromyotonia) has been 
described in connection with mutations affecting gating of Kv7.2 
(Dedek et al., 2001; Wuttke et al., 2007). It is not known how this 
may relate to sensory conduction under physiological conditions 
although no sensory deﬁ  cits have been associated to mutations in 
genes coding Kv7 channels.
CENTRAL TERMINALS OF PRIMARY AFFERENTS
Central terminals are specialized in the release of neurotransmitters 
onto second order dorsal horn neurons. Neurotransmitter release 
can be dynamically controlled by presynaptic contacts and local 
membrane potential. In addition, it has been proposed that exces-
sive depolarization at central terminals may induce backﬁ  ring in 
the afferents contributing to peripheral sensitization (Willis, 1999). 
Therefore, the control of membrane potential and excitability at 
this point is crucial for sensory transmission.
Indirect electrophysiological observations on populations of 
afferent ﬁ  bers indicate that functional Kv7/M currents are present 
in central terminals as well (Rivera-Arconada and Lopez-Garcia, 
2006). Retigabine produces hyperpolarization of terminals and 
reduces the excitability of a range of afferent ﬁ  bers including myeli-
nated and unmyelinated afferents. XE991 has no effect on the ter-
minals when applied alone but blocks the effects of retigabine.
DORSAL ROOT GANGLION CELLS
The cell bodies of primary afferents are grouped in dorsal root 
ganglia. The function of this compartment of primary afferents is 
not as clear as for the other components which are directly involved 
in the transmission of information from the periphery to the spinal 
cord. Action potential invasion of the soma is not required for trans-
mission along the main process and there are no synapses in dorsal 
root ganglion. Somas of primary afferents are classically viewed as 
metabolic factories dedicated to supporting the conducting axon. 
However, the cell soma is normally invaded by action potentials 
running in the main process and this may represent some functional 
advantages (Amir and Devor, 2003).
Among a variety of sodium and potassium ion channels which 
confer the membrane full active electrical properties, the somata 
of dorsal root ganglion cells express Kv7 channels (Linley et al., Frontiers in Molecular Neuroscience  www.frontiersin.org  August 2009  | Volume 2  |  Article 10  |  5
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signals from the brain in order to produce two main forms of 
 output: (1) sensory output to inform brain centers which eventually 
will generate the sensation of pain and (2) motor output to organize 
reﬂ  ex activity. Whereas sensory outputs are generated in the dorsal 
horn, the motor output necessarily requires further processing in 
the ventral horn (Willis and Coggeshall, 2004). In this strategic 
position, the spinal cord is the structure most frequently studied 
to understand central mechanisms of pain processing.
Recently several studies have examined the expression of Kv7 
subunits in the spinal cord although unfortunately a systematic 
description of the laminar distribution is not available yet. Despite 
the ﬁ  rst failed attempts to detect the presence of Kv7 channels 
(Biervert et al., 1998; Smith et al., 2001; Yang et al., 1998), Dedek 
et al. (2001) demonstrated the presence of Kv7.2 and Kv7.3 subunits 
in both the dorsal and ventral horn of the mouse spinal cord using 
in situ hybridization which was later conﬁ  rmed by immunoblots 
and immunohistochemical techniques (Devaux et al., 2004). These 
authors showed the presence of Kv7.2 channels in axon initial seg-
ments throughout the gray matter. The Kv7.3 subunit was also 
found in the gray matter of the spinal cord associated to axon 
initial segments and nodes of motoneurons (Pan et al., 2006). The 
presence of Kv7 subunits in axon initial segments confers a great 
relevance to Kv7 channels in the neuronal integration of synaptic 
inputs since this region of the axon constitutes a subcellular loca-
tion of great importance in the generation of action potentials 
(Stuart et al., 1997). In addition, Kv7.3 channels may be expressed 
by astrocytes (Devaux et al., 2004).
Unpublished observations from our laboratory indicate that 
Kv7.5 subunits are also abundantly expressed in spinal cord neu-
rons. We have used two different antisera previously used for immu-
nohistochemical detection of Kv7.5 channels in nervous tissue 
(Caminos et al., 2007; Yus-Najera et al., 2003) and obtained the 
same picture: clear staining of a considerable proportion of dorsal 
horn (deep and superﬁ  cial) and ventral horn neurons (inter- and 
motorneurons) as well as diffuse staining restricted to superﬁ  cial 
dorsal areas that could label the central terminals of afferent ﬁ  bers. 
The existence of Kv7.5 proteins in spinal cord neurons favors the 
possibility of producing heteromeric channels and adding func-
tional and pharmacological diversity to spinal M currents.
M CURRENTS IN DORSAL HORN NEURONS
The presence of M-like currents sensitive to muscarine and sub-
stance P modulation was ﬁ  rst reported in cultured spinal neurons 
using electrophysiological techniques (Nowak and Macdonald, 
1982, 1983a,b). Then, functional M-like currents were reported in 
Laminae II–IV dorsal horn neurons (Murase et al., 1986). More 
recently, retigabine was shown to produce signiﬁ  cant dose-related 
inhibition of extracellular responses recorded from dorsal horn 
neurons in an in vivo rat preparation (Passmore et al., 2003). In 
this study, retigabine potently suppressed nociceptive processing 
and “wind up” in response to electrical stimuli. Wind-up consists 
of a progressive increment of spike counts in response to repeti-
tive stimulation but only when nociceptive afferents are activated 
(Herrero et al., 2000). We conﬁ  rmed these results in an in vitro 
preparation of the rat spinal cord and showed that XE991 pro-
duced opposite effects and blocked the effects of retigabine (Rivera-
Arconada et al., 2004). With intracellular recordings, we observed 
that retigabine produces hyperpolarization of dorsal horn neurons 
and a decrease in their intrinsic excitability which manifests as 
an augmented rheobase and an increased spike frequency adapta-
tion. XE991 produced a complete reversion of retigabine effects 
indicating a speciﬁ  c action on Kv7 channels; however, XE991 had 
a very weak excitatory effect when applied on its own (Rivera-
Arconada and Lopez-Garcia, 2005). Interestingly, all studies show 
a large proportion of dorsal horn neurons responding to retigabine 
suggesting that Kv7 channels are commonly expressed by dorsal 
horn neurons.
M CURRENTS IN MOTONEURONS
The presence of Kv7 at axon initial segments of motoneurons 
(Devaux et al., 2004; Pan et al., 2006), a structure of great impor-
tance in the generation and the transmission of action potentials, 
strongly argue in favor of a decisive role of these channels at regu-
lating the motor output of the spinal cord. Electrophysiological 
studies using M current modulators also indicate the presence of 
functional M currents in spinal motoneurons regulating its intrin-
sic excitability. In turtle motoneurons both muscarine and XE991 
increased the ﬁ  ring frequency of action potentials by reducing an 
M-like current (Alaburda et al., 2002). Retigabine has been shown 
to depress nociceptive spinal reﬂ  exes having only minor effects 
on non-nociceptive reﬂ  exes (Rivera-Arconada et al., 2004). As in 
the dorsal horn, retigabine reduces responses to the activation of 
nociceptive afferents and wind-up. Motoneurons show a similar 
response to retigabine as that reported for dorsal horn neurons, i.e., 
a decrease in excitability. However, XE991 produced extraordinary 
large increases in excitability compared to the effects seen in dorsal 
horn neurons. This could be due to a differential expression of Kv7 
subunits in both neuronal types. Here again the effects of retigabine 
were prevented by XE991 coapplication indicating a selective action 
of the modulators on Kv7 channels. All motoneurons respond read-
ily to the modulators, indicating a widespread expression of the 
channels (Rivera-Arconada and Lopez-Garcia, 2005).
M CURRENTS, THE SPINAL CORD AND NEUROPATHY
There is abundant evidence supporting the concept of central sen-
sitization (Ji et al., 2003). Although spinal neurons (and neurons 
in other brain centers related to pain processing) are not directly 
affected by a peripheral injury, they and the circuits they form 
become hyperexcitable amplifying subsequent afferent input 
abnormally. There is only one published study trying to evaluate 
possible changes in spinal Kv7 channel function as a consequence 
of peripheral neuropathy (Passmore et al., 2003). This electrophysi-
ological study examined the responses of dorsal horn neurons to 
electrical and natural stimulation in rats that had undergone an 
experimental neuropathy. The authors showed that retigabine pro-
duced similar depressant actions on the excitability of neurons in 
both naïve and treated animals. These results suggest that spinal 
expression of Kv7 channels is maintained after peripheral injury 
and that these channels are still capable to inﬂ  uence excitability 
under the new conditions.
In agreement with the previous results, unpublished observa-
tions from our laboratory indicate that Kv7.5 expression in the 
spinal cord is not essentially altered by peripheral nerve injury. The 
only apparent change is an increase in the percentage of superﬁ  cial Frontiers in Molecular Neuroscience  www.frontiersin.org  August 2009  | Volume 2  |  Article 10  |  6
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dorsal horn neurons expressing Kv7.5. An increase of functional 
M currents would contribute to stabilize neurons rather than to 
make them more excitable and therefore, if anything, this may 
be a homeostatic reaction to compensate for other sources of 
excitability.
Altogether, the data indicate that Kv7 channels are still present 
in the spinal cord after neuropathy and may become valuable tar-
gets for the control of neuronal excitability even in conditions of 
chronic pain and sensitization of the spinal cord.
M CURRENT MODULATION IN BEHAVIORAL MODELS OF 
NEUROPATHIC PAIN
Neuropathic pain patients develop multiple and complex symp-
toms likely reﬂ  ecting a variety of underlying physiopathological 
mechanisms. However, it is generally admitted that neuropathic 
conditions involve damage to peripheral or central components of 
the nociceptive system leading to hyperexcitability of the system 
itself. In peripheral nerves, spontaneous ectopic activity (attrib-
uted to redistribution of K+ and Na+ channels, Devor et al., 1993; 
Rasband et al., 2001) is related to positive symptoms of neuropathy 
(Bostock et al., 2005; Devor, 2006; Ochoa et al., 2005; Orstavik et al., 
2003). Hence, anticonvulsant/antiepileptic drugs such as gabap-
entin and pregabalin have become an important option to treat 
neuropathic pain. Unfortunately, none of these drugs are 100% 
effective and their use is often associated with limiting and adverse 
side effects (Sindrup and Jensen, 1999); consequently, the search 
for novel therapeutic targets is still compelling.
The channel opener retigabine has been proven effective in 
various seizure models (Wuttke and Lerche, 2006) and it is in 
phase III clinical testing to treat pharmaco-resistant focal epilep-
sies at present (Bialer et al., 2009). Since Kv7 channel openers can 
increase the stability of peripheral and central components of the 
nociceptive system, they are potential targets of interest for neu-
ropathic pain. While there is a large body of experimental data on 
the effects of anticonvulsant drugs in the treatment of neuropathic 
pain (Blackburn-Munro and Erichsen, 2005), there is still sparse 
and at times puzzling data on the outcome of Kv7 modulation in 
this scenario. Data with new Kv7 channel openers on models of 
neuropathic pain (like ICA-27243, ﬂ  upirtine or acrylamide) has 
been published only in abstract form (see Wickenden et al., 2004 
for a review) and only two full papers have been published with 
original data on the effects of retigabine on models of neuropathy 
(Blackburn-Munro and Jensen, 2003; Dost et al., 2004). Retigabine 
has been tested in three different models: spinal nerve ligation 
(SNL, Kim and Chung, 1992), chronic constriction injury (CCI, 
Bennett and Xie, 1988) and spared nerve injury (SNI, Decosterd and 
Woolf, 2000). The SNL model involves the ligation or sectioning of 
a dorsal root, the CCI model uses loose ligatures around the sciatic 
nerve and the SNI model sections the tibial and common peroneal 
branches of the sciatic nerve leaving the sural nerve intact. All three 
models have in common the fact that they produce a partial nerve 
injury leaving extensive skin areas supplied by intact ﬁ  bers and 
therefore responsive to natural stimulation. Upon stimulation of 
these areas, allodynia and hyperalgesia are commonly observed. 
A feature that may differentiate between the models is the con-
tribution of intact and damaged ﬁ  bers to the observed symptoms 
(Campbell and Meyer, 2006).
Oral administration of retigabine to SNL rats reduced signs of 
mechanical allodynia (measured as threshold for paw withdrawal). 
In this case, retigabine was more potent than gabapentin (Dost 
et al., 2004). This reduction was dose-dependent and reversed by 
co-administration of linopirdine indicating a speciﬁ  c action on 
Kv7 channels. In these experiments, retigabine also reduced signs of 
heat hyperalgesia (measured as withdrawal latency to a heat source) 
although reversal experiments were not performed.
In a different experiment (Blackburn-Munro and Jensen, 2003), 
comparable oral doses of retigabine did not modify mechanical 
allodynia in CCI or SNI rats but reduced mechanical hyperalgesia 
(assessed as withdrawal time to a pin-prick stimulus). In addition, 
retigabine reduced cold allodynia (assessed as withdrawal time to 
application of an ethyl chloride spray) in CCI rats although reversal 
experiments were not reported. Unfortunately, this later effect was 
not observed in SNI rats. It is important to note that ataxic effects 
of retigabine appeared at doses about twofold greater than those 
required for their analgesic effects.
Other experiments have been performed with Kv7 openers using 
other pain models like intraplantar injection of capsaicin or forma-
lin (Blackburn-Munro and Jensen, 2003; Passmore et al., 2003). In 
both experiments oral administration of retigabine reduced signs 
of pain and these effects were antagonized by co-administration of 
XE991. One more experiment has been performed using a model 
of muscular pain which involves intramuscular injections of acidic 
saline. In this case intraperitoneal administration of both retigabine 
and ﬂ  upirtine were shown to reduce signs of pain (Nielsen et al., 
2004).
Signs of cognitive distress or spontaneous pain may accompany 
neuropathic syndromes (Andersen and Tuﬁ  k, 2003; Djouhri et al., 
2006; LaBuda and Fuchs, 2000; Monassi et al., 2003; Pedersen and 
Blackburn-Munro, 2006). In this regard, retigabine has been shown 
to reduce anxiety in models of unconditioned anxiety but not in 
models of conditioned anxiety (Korsgaard et al., 2005; Munro and 
Dalby-Brown, 2007). Mood modulation could be an additional 
mechanism for Kv7 channel openers to improve neuropathic pain 
conditions.
The general outcome of behavioral experiments is that open-
ing of Kv7 channels tends to reduce signs of pain in models of 
neuropathy. This is hopeful; however, more experiments will be 
required to clarify present discrepancies and to establish the pain 
conditions more susceptible to improve with retigabine and other 
Kv7 channel openers.
CONCLUDING REMARKS
Although we may be looking at early times of research on the via-
bility of M current modulation as a strategy for pain therapy, an 
emerging body of interesting and promising data is already avail-
able. Unfortunately many questions remain unanswered.
It is now very clear that functional M currents are present 
in primary afferents and spinal neurons, both key elements for 
nociceptive processing. In addition, they may be present in other 
areas related to pain processing. Are these channels involved in 
the generation or maintenance of sensitized states leading to 
lasting pain? On the basis of existing data, it seems possible that 
endogenous modulation of the M current in dorsal root gan-
glion cells contributes to make sensory ﬁ  bers more excitable Frontiers in Molecular Neuroscience  www.frontiersin.org  August 2009  | Volume 2  |  Article 10  |  7
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after peripheral inﬂ  ammation (Crozier et al., 2007; Linley et al., 
2008). However, this working hypothesis and its application to 
neuropathy will require further validation. On the other hand, 
there is no evidence supporting a contribution of spinal M cur-
rents to the initiation of central sensitization. A decreased expres-
sion of the channel or the functional current in the spinal cord 
could be interpreted as an active mechanism leading to increase 
the excitability of spinal neurons and therefore as a contribu-
tion towards maintaining spinal sensitization. Such decreased 
expression or function has not been found (see ‘M currents, the 
spinal cord and neuropathy’).
Given this extensive expression of Kv7 channels in the noci-
ceptive system which persists after injury, what is the interest 
of Kv7 channels as targets for neuropathic pain? The outcome 
of behavioral studies is scarce but positive. Data available so far 
indicate that potentiation of M currents tend to reduce signs of 
pain in neuropathic animals. Basic research on primary afferents 
suggests that the site of injury at the periphery may be a particu-
larly interesting point for the action of modulators (Lang et al., 
2008; Roza and Lopez-Garcia, 2008). Some forms of neuropathy 
may beneﬁ  t from the development of Kv7 openers which do not 
cross the blood brain barrier or compounds for topical applica-
tion that can be directly applied over the damaged nerves and be 
absorbed through the skin. Data from spinal cord research draws 
a much more complicated picture. M currents are present in most 
spinal neurons (sensory and motor) and other areas of the nerv-
ous system. Therefore, compounds designed to act at this level 
may show little selectivity for pain processing. A great amount of 
information will be required to reﬁ  ne centrally acting Kv7 open-
ers. Key data in this process are detailed maps of the expression 
of individual Kv7 subunits by neurons of the nociceptive system 
and the development of subunit-speciﬁ  c openers. However, as 
with many other receptors and ion channels, there is no guarantee 
that a particular Kv7 subunit is central to pain processing during 
neuropathic pain.
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